Contact this trialFirst, we need to learn more about you.
SGLT-2 Inhibitor
Empagliflozin for Heart Failure
Recruiting4 awardsPhase 3
Dallas, Texas
This trial will help researchers understand how a new diabetes drug can help people with heart failure. The study will look at how well the drug works and what side effects it may have.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.